RFCA
COLL icon

R&F Capital Advisors’s Collegium Pharmaceutical COLL Stock Holding History

R&F Capital Advisors’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$252K Buy
+25,067
New +$373K 0.07% 462

Other funds holding COLL

Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

R&F Capital Advisors's COLL Position: Q1 2017 in Review

R&F Capital Advisors opened a new position in Collegium Pharmaceutical (COLL) in Q1 2017: 25,067 shares worth $252K. The stake represents 0.07% of the portfolio and ranks #462 among its holdings.

83 funds tracked by Wall St. Rank hold COLL as of Q1 2017.

  • R&F Capital Advisors held 25,067 shares of Collegium Pharmaceutical worth $252K as of Q1 2017.
  • Collegium Pharmaceutical was a new R&F Capital Advisors position in Q1 2017.
  • Collegium Pharmaceutical made up 0.07% of R&F Capital Advisors's portfolio in Q1 2017, its #462 holding.
  • 83 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2017.

Based on R&F Capital Advisors's 13F filing for Q1 2017, filed 15 May 2017.